Stay updated on Sorafenib Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the Sorafenib Nivolumab in Liver Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange Detected- Publications section was added, including a new PubMed reference: Phase II trial with nivolumab and sorafenib in HCC identified enrichment of immunosuppressive monocytes in patients with Child-Pugh B liver dysfunction. These publications are automatically filled from PubMed.SummaryDifference0.4%

- Check22 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.2 was added. The funding-status notice about a lapse in government funding and the Revision: v3.4.1 notice were removed.SummaryDifference0.4%

- Check58 days agoChange DetectedAdded a site-wide government funding/status notice and updated the page revision to v3.4.1, replacing the previous v3.4.0.SummaryDifference0.4%

- Check65 days agoChange DetectedShow glossary has been added; the page now displays 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' metadata, while the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' labels were removed.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Sorafenib Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sorafenib Nivolumab in Liver Cancer Clinical Trial page.